Health
Could Galectin-3 be a potential biomarker to help identify severe COVID-19 early? – News-Medical.Net
Researchers have measured the galectin-3 levels in the sera of hospitalized patients. They found initial high levels indicate patients will become severely ill,…
Researchers have measured the galectin-3 levels in the sera of hospitalized patients with coronavirus disease 2019 (COVID-19). They found initial high levels indicate patients will become severely ill, suggesting it could be used as a predictor of severe disease.
As the COVID-19 pandemic continues to claim more lives, with many patients becoming severely ill, biomarkers that can predict disease severity will help better treat such patients. Patients with severe disease show a hyperinflammatory response…
-
General22 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General20 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBrisbane bands unite to help bassist’s cancer fight
-
Noosa News15 hours agoThe Laundry Lady secures $1M to fuel international expansion